229 related articles for article (PubMed ID: 7757973)
1. Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-xL.
Schwarze MM; Hawley RG
Cancer Res; 1995 Jun; 55(11):2262-5. PubMed ID: 7757973
[TBL] [Abstract][Full Text] [Related]
2. Role of bcl-X(L) in the control of apoptosis in murine myeloma cells.
Gauthier ER; Piché L; Lemieux G; Lemieux R
Cancer Res; 1996 Mar; 56(6):1451-6. PubMed ID: 8640839
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression.
Akbar AN; Borthwick NJ; Wickremasinghe RG; Panayoitidis P; Pilling D; Bofill M; Krajewski S; Reed JC; Salmon M
Eur J Immunol; 1996 Feb; 26(2):294-9. PubMed ID: 8617294
[TBL] [Abstract][Full Text] [Related]
4. Regulation of bcl-2, bcl-XL and bax in the control of apoptosis by hematopoietic cytokines and dexamethasone.
Lotem J; Sachs L
Cell Growth Differ; 1995 Jun; 6(6):647-53. PubMed ID: 7669718
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1.
Jourdan M; De Vos J; Mechti N; Klein B
Cell Death Differ; 2000 Dec; 7(12):1244-52. PubMed ID: 11175262
[TBL] [Abstract][Full Text] [Related]
6. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death.
Boussiotis VA; Lee BJ; Freeman GJ; Gribben JG; Nadler LM
J Immunol; 1997 Oct; 159(7):3156-67. PubMed ID: 9317113
[TBL] [Abstract][Full Text] [Related]
7. Bcl-xS and Bax induce different apoptotic pathways in PC12 cells.
Lindenboim L; Yuan J; Stein R
Oncogene; 2000 Mar; 19(14):1783-93. PubMed ID: 10777212
[TBL] [Abstract][Full Text] [Related]
8. IFN-gamma upregulates anti-apoptotic gene expression and inhibits apoptosis in IL-3-dependent hematopoietic cells.
Sekiya M; Adachi M; Takayama S; Reed JC; Imai K
Biochem Biophys Res Commun; 1997 Oct; 239(2):401-6. PubMed ID: 9344841
[TBL] [Abstract][Full Text] [Related]
9. The apoptosis and proliferation of SAC-activated B cells by IL-10 are associated with changes in Bcl-2, Bcl-xL, and Mcl-1 expression.
Li L; Krajewski S; Reed JC; Choi YS
Cell Immunol; 1997 May; 178(1):33-41. PubMed ID: 9184696
[TBL] [Abstract][Full Text] [Related]
10. The survival of IL-6-dependent myeloma cells critically relies on their capability to transit the G1 to S phase interval of the cell cycle.
Côté S; Lemieux R; Simard C
Cell Signal; 2005 May; 17(5):615-24. PubMed ID: 15683736
[TBL] [Abstract][Full Text] [Related]
11. Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells.
Walker A; Taylor ST; Hickman JA; Dive C
Cancer Res; 1997 May; 57(10):1939-45. PubMed ID: 9157989
[TBL] [Abstract][Full Text] [Related]
12. v-Abl protein tyrosine kinase (PTK) mediated suppression of apoptosis is associated with the up-regulation of Bcl-XL.
Chen Q; Turner J; Watson AJ; Dive C
Oncogene; 1997 Oct; 15(18):2249-54. PubMed ID: 9393984
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity.
Moreno MB; Memon SA; Zacharchuk CM
J Immunol; 1996 Nov; 157(9):3845-9. PubMed ID: 8892614
[TBL] [Abstract][Full Text] [Related]
14. Relative level of expression of Bax and Bcl-XL determines the cellular fate of apoptosis/necrosis induced by the overexpression of Bax.
Shinoura N; Yoshida Y; Asai A; Kirino T; Hamada H
Oncogene; 1999 Oct; 18(41):5703-13. PubMed ID: 10523849
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
Henkels KM; Turchi JJ
Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
[TBL] [Abstract][Full Text] [Related]
16. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines.
Nuñez G; London L; Hockenbery D; Alexander M; McKearn JP; Korsmeyer SJ
J Immunol; 1990 May; 144(9):3602-10. PubMed ID: 2184193
[TBL] [Abstract][Full Text] [Related]
17. Role of Bax in apoptosis of IL-3-dependent cells.
Low W; Olmos-Centenera G; Madsen C; Leverrier Y; Collins MK
Oncogene; 2001 Jul; 20(33):4476-83. PubMed ID: 11494143
[TBL] [Abstract][Full Text] [Related]
18. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
Sawada M; Nakashima S; Banno Y; Yamakawa H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Nozawa Y
Oncogene; 2000 Jul; 19(31):3508-20. PubMed ID: 10918609
[TBL] [Abstract][Full Text] [Related]
19. Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis.
Hinz S; Trauzold A; Boenicke L; Sandberg C; Beckmann S; Bayer E; Walczak H; Kalthoff H; Ungefroren H
Oncogene; 2000 Nov; 19(48):5477-86. PubMed ID: 11114725
[TBL] [Abstract][Full Text] [Related]
20. Mcl-1 mediates cytokine deprivation induced apoptosis of human myeloma cell line XG-7.
Song L; Li Y; Sun Y; Shen B
Chin Med J (Engl); 2002 Aug; 115(8):1241-3. PubMed ID: 12215301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]